Clinical Hematology

Front Cover
Mosby/Elsevier, 2006 - Medical - 1420 pages
0 Reviews
Written by a young, innovative author group, this exciting new book gives you the clinically relevant aspects of hematology in an innovative, unique format. The book is structured to comprehensively cover the complete scope of hematology, but allows fast access to key information you need in everyday practice. A section on consultative hematology includes chapters on special populations (pregnancy, pediatrics, geriatrics), infections of marrow and blood, and hematologic problems of medical practice and surgery. You'll also find a section on tools for the hematologist, covering clinical aspects of transfusion, transplantation, and the latest innovative laboratory procedures.

  • Provides critical information relevant to everyday practice, reflecting the way hematology is practiced today.
  • Covers basic science only as it relates to clinical practice.
  • Utilizes full-color photographs, illustrations, and functional drawings to highlight critical information and difficult concepts.
  • Uses consistent, templated chapters to make essential information uncommonly easy to find.
  • Offers a unique approach by innovative experts in the field.
  • Includes a CD-ROM containing all of the book's figures, tables, algorithms, and charts all downloadable for PowerPoint® presentations, as well as a comprehensive reference library.

What people are saying - Write a review

We haven't found any reviews in the usual places.

About the author (2006)

Stanton L Gerson is Director of the Case Comprehensive Cancer Center & the National Center for Regenerative Medicine at Case Western Reserve University and Director of University Hospitals Seidman Cancer Center in Cleveland. Dr. Gerson studies DNA repair, stem cells and cancer therapy. He showed that over-expression of the MGMT DNA repair gene could prevent cancer and that a mutant form of MGMT protects hematopoietic stem cells from chemotherapy using lentiviral gene therapy. He has interrogated MGMT, MMR and BER DNA repair pathways as targets for cancer therapy, and proposed that methoxyamine would block base excision repair used in combination with chemotherapy. Dr. Gerson also directed the initial use of mesenchymal stem cells (MSCs) in bone marrow transplantation & in gene therapy.

Bibliographic information